← Screener · Thematic / sector
DRUGBetashares · Equity - Global Sectors · Equity · Global ex-Australia · Currency hedged
Betashares Global Healthcare ETF - Currency Hedged
Fee p.a.
0.57%
ASX report
Fund size
A$173m
12m flow A$-4.9m
Yield
3.8%
2 payments / yr
Volatility 3y
15.0%
annualised
Max DD 3y
−20.4%
all-time −26.8%
Listed
2016
9 Aug 2016 · spread 0.20%
$8k$10k$12k$14k$16k$18k$20k$22k$24k201620182020202220242026
Performance
Period
Total
ASX
1 month
5.1%
0.5%
3 months
14.7%
—
6 months
7.0%
—
Year to date
7.6%
—
1 year
20.1%
18.8%
3 years p.a.
7.3%
5.8%
5 years p.a.
4.2%
4.2%
10 years p.a.
8.4%
—
Since listing p.a.
8.0%
—
Total return to 4 Sept 2026, distributions reinvested, before franking. ASX figures are to 31 July 2026 and gross of franking, so they run higher for franked Australian funds.
Sharpe 3y 0.22Vol 1y 15.6%Vol 5y 15.1%Max DD 1y −10.7%Max DD 5y −20.4%Best year 23.6%89% positive years
Calendar-year returns
2017
18.2%
2018
2.4%
2019
21.9%
2020
5.1%
2021
23.6%
2022
−3.4%
2023
1.1%
2024
2.2%
2025
12.2%
2026
7.6%
Where the money is
Look-through exposure as at 2 Sept 2026 · 59 securities · top 10 = 51.5%
Country
United States79.7%
Switzerland6.5%
United Kingdom3.1%
Japan2.9%
Denmark2.5%
China1.8%
France1.0%
Netherlands0.9%
Germany0.9%
Belgium0.4%
Sector
Health Care99.3%
Consumer Staples0.7%
Top holdings
JOHNSON & JOHNSONUnited States
8.8%
ELI LILLY & COUnited States
7.6%
ABBVIE INCUnited States
6.6%
UNITEDHEALTH GROUP INCUnited States
5.1%
ROCHE HOLDING AGUnited States
4.9%
MERCK & CO INCUnited States
4.6%
NOVARTIS AGSwitzerland
3.9%
THERMO FISHER SCIENTIFIC INCUnited States
3.5%
AMGEN INCUnited States
3.3%
ASTRAZENECA PLCUnited Kingdom
3.1%
ABBOTT LABORATORIESUnited States
2.9%
GILEAD SCIENCES INCUnited States
2.6%
NOVO NORDISK A/SDenmark
2.5%
PFIZER INCUnited States
2.5%
DANAHER CORPUnited States
2.2%
Top 15 of 59 holdings.
Most similar funds
Overlap is the share of the portfolio held in common, look-through. Correlation is of daily returns. High overlap means close substitutes.
Code
Fund
Fee
Overlap
Corr 3y